RASSF1 and hepatocellular carcinoma: In particular, an intriguing study showed that, in the hepatitic liver (affected by chronic hepatitis and/or cirrhosis, dysplastic nodules, or HCC), the RASSF1A gene promoter was extensively methylated, with a methylation degree that increased from regenerative conditions (cirrhosis) to dysplastic nodules, to HCC [21].